BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3555766)

  • 1. Skin changes following bone marrow transplantation.
    McConn R
    Cancer Nurs; 1987 Apr; 10(2):82-4. PubMed ID: 3555766
    [No Abstract]   [Full Text] [Related]  

  • 2. [Graft vs host disease of the skin].
    Martín Ortega E
    Med Clin (Barc); 1990 Feb; 94(5):180-3. PubMed ID: 2325478
    [No Abstract]   [Full Text] [Related]  

  • 3. [Whole body irradiation in conditioning for bone marrow transplantation. Experiences with 35 cases of leukemia].
    Prosperini G; Santeusanio E; Di Bartolomeo P; Iacone A; Muzii G
    Radiol Med; 1985 Apr; 71(4):243-7. PubMed ID: 3901148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mucocutaneous and salivary manifestations of the graft vs host reaction after bone marrow transplantation].
    d'Agay MF; Brocheriou C; Kuffer R; Gluckman E; Janin A; Saurat JH
    Rev Stomatol Chir Maxillofac; 1984; 85(5):370-4. PubMed ID: 6393313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of dermatologic complications of chronic graft versus host disease: a case study.
    DeMeyer ES; Fletcher MA; Buchsel PC
    Clin J Oncol Nurs; 1997 Oct; 1(4):95-104. PubMed ID: 9410658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life.
    Ziemer M; Thiele JJ; Gruhn B; Elsner P
    J Am Acad Dermatol; 2004 Aug; 51(2):318-9. PubMed ID: 15280858
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of cutaneous 'graft-versus-host like' reaction by recombinant IL-2 after autologous bone marrow transplantation.
    Costello R; Blaise D; Jacquemier J; Monges G; Stoppa AM; Viens P; Olive D; Bouabdallah M; Brandely ; Gastaut JA
    Bone Marrow Transplant; 1995 Jul; 16(1):199-200. PubMed ID: 7581125
    [No Abstract]   [Full Text] [Related]  

  • 8. Dental management of children undergoing bone marrow transplantation.
    Lucas VS; Roberts GJ
    Dent Update; 1995; 22(6):246-51. PubMed ID: 8948171
    [No Abstract]   [Full Text] [Related]  

  • 9. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin changes associated with hematologic and oncologic diseases in children.
    Ganick DJ
    N Y State J Med; 1992 Jun; 92(6):256-61. PubMed ID: 1641210
    [No Abstract]   [Full Text] [Related]  

  • 11. Skin and stomach graft versus host disease after syngeneic BMT in CML: a case report.
    Pelosini M; Galimberti S; Benedetti E; Caracciolo F; Fazzi R; Petrini M; Papineschi F
    Leuk Res; 2007 Nov; 31(11):1603-4. PubMed ID: 17328949
    [No Abstract]   [Full Text] [Related]  

  • 12. Ocular manifestations in bone marrow transplantation.
    Spires R
    J Ophthalmic Nurs Technol; 1993; 12(5):208-10. PubMed ID: 8301680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
    Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
    Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary function at the early stage after bone marrow transplantation].
    Hatta Y; Itoh T; Baba M; Izumi T; Sasaki I; Shimojima H; Miyajima T; Aizawa S; Takeuchi J; Horikoshi A; Ohshima T; Sawada U; Amemiya Y; Horie T
    Rinsho Ketsueki; 1998 Sep; 39(9):645-51. PubMed ID: 9796397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Triple secondary malignancy of gingiva, palate and esophagus after an allogeneic bone marrow transplantation for cutaneous T-cell lymphoma].
    Koharazawa H; Yamaji S; Takasaki H; Takabayashi M; Fujimaki K; Taguchi J; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 Jul; 46(7):496-500. PubMed ID: 16440741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation for severe aplastic anemia from HLA identical siblings.
    Bacigalupo A
    Haematologica; 1999 Jan; 84(1):2-4. PubMed ID: 10091385
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pubertal development after bone marrow transplantation in adolescents.
    Cisternino M; Bozzola M; Locatelli F; Lahlou N; Gambarana D; Manfredi P; Giorgiani G; Milicia C; Roger M; Severi F
    Bone Marrow Transplant; 1991; 8 Suppl 1():54-5. PubMed ID: 1760642
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term renal function following bone marrow transplantation.
    Grönroos MH; Bolme P; Winiarski J; Berg UB
    Bone Marrow Transplant; 2007 Jun; 39(11):717-23. PubMed ID: 17401393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.